{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:46:31Z","timestamp":1775123191098,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100010495","name":"Department of Radiology, University of Wisconsin-Madison","doi-asserted-by":"publisher","award":["Internal department grant"],"award-info":[{"award-number":["Internal department grant"]}],"id":[{"id":"10.13039\/100010495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007870","name":"Department of Obstetrics and Gynecology, University of Wisconsin-Madison","doi-asserted-by":"publisher","award":["Internal department grant"],"award-info":[{"award-number":["Internal department grant"]}],"id":[{"id":"10.13039\/100007870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-023-03957-3","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T06:02:22Z","timestamp":1685599342000},"page":"3643-3652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Distribution of prostate specific membrane antigen (PSMA) on PET-MRI in patients with and without ovarian cancer"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1976-935X","authenticated-orcid":false,"given":"Elizabeth A.","family":"Sadowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Lees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan B.","family":"McMillian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna E.","family":"Kusmirek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve Y.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Barroilhet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"key":"3957_CR1","unstructured":"https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html. SEER Stat Fact Sheets: Ovarian Cancer. Accessed November 18, 2020."},{"key":"3957_CR2","unstructured":"http:\/\/www.cancer.org\/cancer\/ovariancancer\/detailedguide\/ovarian-cancer-survival-rates. American Cancer Society. http:\/\/www.cancer.org\/cancer\/ovariancancer\/detailedguide\/ovarian-cancer-survival-rates. Published Accessed November 18, 2020."},{"issue":"10022","key":"3957_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/s0140-6736(15)01236-2","volume":"387","author":"RH Verheijen","year":"2016","unstructured":"Verheijen RH, Zweemer RP. Screening to improve ovarian cancer prognosis? Lancet (London, England) 2016;387(10022):921-923. https:\/\/doi.org\/10.1016\/s0140-6736(15)01236-2","journal-title":"Lancet (London, England)"},{"issue":"9251","key":"3957_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/s0140-6736(00)03590-x","volume":"357","author":"I Vergote","year":"2001","unstructured":"Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P, Gore ME, Kaern J, Verrelst H, Sjovall K, Timmerman D, Vandewalle J, Van Gramberen M, Trope CG. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet (London, England) 2001;357(9251):176-182. doi: https:\/\/doi.org\/10.1016\/s0140-6736(00)03590-x","journal-title":"Lancet (London, England)"},{"issue":"12","key":"3957_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11912-017-0640-3","volume":"19","author":"SR Khan","year":"2017","unstructured":"Khan SR, Arshad M, Wallitt K, Stewart V, Bharwani N, Barwick TD. What's New in Imaging for Gynecologic Cancer? Current oncology reports 2017;19(12):85. https:\/\/doi.org\/10.1007\/s11912-017-0640-3","journal-title":"Current oncology reports"},{"issue":"10","key":"3957_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.diii.2018.11.007","volume":"100","author":"S Nougaret","year":"2019","unstructured":"Nougaret S, Tardieu M, Vargas HA, Reinhold C, Vande Perre S, Bonanno N, Sala E, Thomassin-Naggara I. Ovarian cancer: An update on imaging in the era of radiomics. Diagnostic and interventional imaging 2019;100(10):647-655. https:\/\/doi.org\/10.1016\/j.diii.2018.11.007","journal-title":"Diagnostic and interventional imaging"},{"issue":"Suppl 2","key":"3957_CR7","doi-asserted-by":"publisher","first-page":"13s","DOI":"10.2967\/jnumed.118.220566","volume":"60","author":"T Langbein","year":"2019","unstructured":"Langbein T, Weber WA, Eiber M. Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2019;60(Suppl 2):13s-19s. https:\/\/doi.org\/10.2967\/jnumed.118.220566","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"key":"3957_CR8","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.2147\/ott.s140671","volume":"10","author":"A Yordanova","year":"2017","unstructured":"Yordanova A, Eppard E, K\u00fcrpig S, Bundschuh RA, Sch\u00f6nberger S, Gonzalez-Carmona M, Feldmann G, Ahmadzadehfar H, Essler M. Theranostics in nuclear medicine practice. OncoTargets and therapy 2017;10:4821-4828. https:\/\/doi.org\/10.2147\/ott.s140671","journal-title":"OncoTargets and therapy"},{"issue":"11","key":"3957_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.nucmedbio.2016.08.006","volume":"43","author":"MRA Pillai","year":"2016","unstructured":"Pillai MRA, Nanabala R, Joy A, Sasikumar A, Russ Knapp FF. Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer. Nuclear medicine and biology 2016;43(11):692-720. https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.08.006","journal-title":"Nuclear medicine and biology"},{"issue":"3","key":"3957_CR10","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1016\/s1470-2045(19)30821-6","volume":"21","author":"K Herrmann","year":"2020","unstructured":"Herrmann K, Schwaiger M, Lewis JS, Solomon SB, McNeil BJ, Baumann M, Gambhir SS, Hricak H, Weissleder R. Radiotheranostics: a roadmap for future development. The Lancet Oncology 2020;21(3):e146-e156. https:\/\/doi.org\/10.1016\/s1470-2045(19)30821-6","journal-title":"The Lancet Oncology"},{"issue":"8","key":"3957_CR11","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.2967\/jnumed.117.191023","volume":"58","author":"WP Fendler","year":"2017","unstructured":"Fendler WP, Rahbar K, Herrmann K, Kratochwil C, Eiber M. (177)Lu-PSMA Radioligand Therapy for Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017;58(8):1196-1200. https:\/\/doi.org\/10.2967\/jnumed.117.191023","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"issue":"3","key":"3957_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00259-017-3895-x","volume":"45","author":"FE von Eyben","year":"2018","unstructured":"von Eyben FE, Roviello G, Kiljunen T, Uprimny C, Virgolini I, Kairemo K, Joensuu T. Third-line treatment and (177)Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review. European journal of nuclear medicine and molecular imaging 2018;45(3):496-508. https:\/\/doi.org\/10.1007\/s00259-017-3895-x","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"3957_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","volume":"41","author":"PM Webb","year":"2017","unstructured":"Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best practice & research Clinical obstetrics & gynaecology 2017;41:3-14. https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.08.006","journal-title":"Best practice & research Clinical obstetrics & gynaecology"},{"key":"3957_CR14","doi-asserted-by":"publisher","unstructured":"Lee JM, Minasian L, Kohn EC. New strategies in ovarian cancer treatment. Cancer 2019;125 Suppl 24(Suppl 24):4623\u20134629. https:\/\/doi.org\/10.1002\/cncr.32544","DOI":"10.1002\/cncr.32544"},{"issue":"4","key":"3957_CR15","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s00268-005-0544-5","volume":"30","author":"Y Kinoshita","year":"2006","unstructured":"Kinoshita Y, Kuratsukuri K, Landas S, Imaida K, Rovito PM, Jr., Wang CY, Haas GP. Expression of prostate-specific membrane antigen in normal and malignant human tissues. World journal of surgery 2006;30(4):628-636. https:\/\/doi.org\/10.1007\/s00268-005-0544-5","journal-title":"World journal of surgery"},{"issue":"1","key":"3957_CR16","first-page":"81","volume":"3","author":"DA Silver","year":"1997","unstructured":"Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(1):81-85.","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"3957_CR17","doi-asserted-by":"publisher","unstructured":"Van de Wiele C, Sathekge M, de Spiegeleer B, de Jonghe PJ, Beels L, Maes A. PSMA-Targeting Positron Emission Agents for Imaging Solid Tumors Other Than Non-Prostate Carcinoma: A Systematic Review. International journal of molecular sciences 2019;20(19). https:\/\/doi.org\/10.3390\/ijms20194886","DOI":"10.3390\/ijms20194886"},{"issue":"6","key":"3957_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2967\/jnumed.117.203570","volume":"59","author":"RA Salas Fragomeni","year":"2018","unstructured":"Salas Fragomeni RA, Amir T, Sheikhbahaei S, Harvey SC, Javadi MS, Solnes LB, Kiess AP, Allaf ME, Pomper MG, Gorin MA, Rowe SP. Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2018;59(6):871-877. https:\/\/doi.org\/10.2967\/jnumed.117.203570","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"issue":"6","key":"3957_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/apm.12195","volume":"122","author":"AG Wernicke","year":"2014","unstructured":"Wernicke AG, Varma S, Greenwood EA, Christos PJ, Chao KS, Liu H, Bander NH, Shin SJ. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2014;122(6):482-489. https:\/\/doi.org\/10.1111\/apm.12195","journal-title":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica"},{"key":"3957_CR20","doi-asserted-by":"publisher","unstructured":"Schmidt LH, Heitk\u00f6tter B, Schulze AB, Schliemann C, Steinestel K, Trautmann M, Marra A, Hillejan L, Mohr M, Evers G, Wardelmann E, Rahbar K, G\u00f6rlich D, Lenz G, Berdel WE, Hartmann W, Wiewrodt R, Huss S. Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer. PloS one 2017;12(10):e0186280. https:\/\/doi.org\/10.1371\/journal.pone.0186280","DOI":"10.1371\/journal.pone.0186280"},{"issue":"5","key":"3957_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/rlu.0000000000001139","volume":"41","author":"D Shetty","year":"2016","unstructured":"Shetty D, Loh H, Bui C, Mansberg R, Stevanovic A. Elevated 68Ga Prostate-Specific Membrane Antigen Activity in Metastatic Non-Small Cell Lung Cancer. Clinical nuclear medicine 2016;41(5):414-416. https:\/\/doi.org\/10.1097\/rlu.0000000000001139","journal-title":"Clinical nuclear medicine"},{"issue":"12","key":"3957_CR22","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.humpath.2009.06.003","volume":"40","author":"MC Haffner","year":"2009","unstructured":"Haffner MC, Kronberger IE, Ross JS, Sheehan CE, Zitt M, M\u00fchlmann G, Ofner D, Zelger B, Ensinger C, Yang XJ, Geley S, Margreiter R, Bander NH. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Human pathology 2009;40(12):1754-1761. https:\/\/doi.org\/10.1016\/j.humpath.2009.06.003","journal-title":"Human pathology"},{"key":"3957_CR23","doi-asserted-by":"publisher","unstructured":"Samplaski MK, Heston W, Elson P, Magi-Galluzzi C, Hansel DE. Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(11):1521-1529. https:\/\/doi.org\/10.1038\/modpathol.2011.112","DOI":"10.1038\/modpathol.2011.112"},{"issue":"9","key":"3957_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/rlu.0000000000002701","volume":"44","author":"S Kuyumcu","year":"2019","unstructured":"Kuyumcu S, Has-Simsek D, Iliaz R, Sanli Y, Buyukkaya F, Akyuz F, Turkmen C. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET\/CT. Clinical nuclear medicine 2019;44(9):702-706. https:\/\/doi.org\/10.1097\/rlu.0000000000002701","journal-title":"Clinical nuclear medicine"},{"issue":"1","key":"3957_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00259-016-3360-2","volume":"44","author":"LM Sawicki","year":"2017","unstructured":"Sawicki LM, Buchbender C, Boos J, Giessing M, Ermert J, Antke C, Antoch G, Hautzel H. Diagnostic potential of PET\/CT using a (68)Ga-labelled prostate-specific membrane antigen ligand in whole-body staging of renal cell carcinoma: initial experience. European journal of nuclear medicine and molecular imaging 2017;44(1):102-107. https:\/\/doi.org\/10.1007\/s00259-016-3360-2","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"5","key":"3957_CR26","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s11307-018-01307-0","volume":"21","author":"T Ahn","year":"2019","unstructured":"Ahn T, Roberts MJ, Abduljabar A, Joshi A, Perera M, Rhee H, Wood S, Vela I. A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC). Mol Imaging Biol 2019;21(5):799-807. https:\/\/doi.org\/10.1007\/s11307-018-01307-0","journal-title":"Mol Imaging Biol"},{"issue":"10","key":"3957_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s12149-015-1017-z","volume":"29","author":"SP Rowe","year":"2015","unstructured":"Rowe SP, Gorin MA, Hammers HJ, Som Javadi M, Hawasli H, Szabo Z, Cho SY, Pomper MG, Allaf ME. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET\/CT. Annals of nuclear medicine 2015;29(10):877-882. https:\/\/doi.org\/10.1007\/s12149-015-1017-z","journal-title":"Annals of nuclear medicine"},{"key":"3957_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/pai.0000000000000297","author":"AG Wernicke","year":"2016","unstructured":"Wernicke AG, Kim S, Liu H, Bander NH, Pirog EC. Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy. Applied immunohistochemistry & molecular morphology : AIMM 2016. https:\/\/doi.org\/10.1097\/pai.0000000000000297","journal-title":"Applied immunohistochemistry & molecular morphology : AIMM"},{"key":"3957_CR29","doi-asserted-by":"publisher","unstructured":"Hofstetter G, Grech C, Pils D, Pammer J, Neudert B, P\u00f6tsch N, Baltzer P, Traub-Weidinger T, Seebacher V, Aust S. Prostate-Specific Membrane Antigen (PSMA) Expression in Tumor-Associated Neovasculature Is an Independent Prognostic Marker in Patients with Ovarian Cancer. J Pers Med 2022;12(4). https:\/\/doi.org\/10.3390\/jpm12040551","DOI":"10.3390\/jpm12040551"},{"issue":"4","key":"3957_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/pai.0000000000000297","volume":"25","author":"AG Wernicke","year":"2017","unstructured":"Wernicke AG, Kim S, Liu H, Bander NH, Pirog EC. Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy. Applied immunohistochemistry & molecular morphology : AIMM 2017;25(4):271-276. https:\/\/doi.org\/10.1097\/pai.0000000000000297","journal-title":"Applied immunohistochemistry & molecular morphology : AIMM"},{"key":"3957_CR31","doi-asserted-by":"publisher","first-page":"1025475","DOI":"10.3389\/fonc.2022.1025475","volume":"12","author":"U Metser","year":"2022","unstructured":"Metser U, Kulanthaivelu R, Chawla T, Johnson S, Avery L, Hussey D, Veit-Haibach P, Bernardini M, Hogen L. (18)F-DCFPyL PET\/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study. Frontiers in oncology 2022;12:1025475. https:\/\/doi.org\/10.3389\/fonc.2022.1025475","journal-title":"Frontiers in oncology"},{"issue":"9","key":"3957_CR32","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1007\/s00330-017-4779-y","volume":"27","author":"HA Vargas","year":"2017","unstructured":"Vargas HA, Veeraraghavan H, Micco M, Nougaret S, Lakhman Y, Meier AA, Sosa R, Soslow RA, Levine DA, Weigelt B, Aghajanian C, Hricak H, Deasy J, Snyder A, Sala E. A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome. European radiology 2017;27(9):3991-4001. https:\/\/doi.org\/10.1007\/s00330-017-4779-y","journal-title":"European radiology"},{"issue":"6","key":"3957_CR33","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1007\/s00330-020-07560-8","volume":"31","author":"L Beer","year":"2021","unstructured":"Beer L, Martin-Gonzalez P, Delgado-Ortet M, Reinius M, Rundo L, Woitek R, Ursprung S, Escudero L, Sahin H, Funingana IG, Ang JE, Jimenez-Linan M, Lawton T, Phadke G, Davey S, Nguyen NQ, Markowetz F, Brenton JD, Crispin-Ortuzar M, Addley H, Sala E. Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer. European radiology 2021;31(6):3765-3772. https:\/\/doi.org\/10.1007\/s00330-020-07560-8","journal-title":"European radiology"},{"key":"3957_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2020.12.022","author":"C Reinhold","year":"2021","unstructured":"Reinhold C, Rockall A, Sadowski EA, Siegelman ES, Maturen KE, Vargas HA, Forstner R, Glanc P, Andreotti RF, Thomassin-Naggara I. Ovarian-Adnexal Reporting Lexicon for MRI: A White Paper of the ACR Ovarian-Adnexal Reporting and Data Systems MRI Committee. Journal of the American College of Radiology : JACR 2021. https:\/\/doi.org\/10.1016\/j.jacr.2020.12.022","journal-title":"Journal of the American College of Radiology : JACR"},{"issue":"1","key":"3957_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1148\/radiol.204371","volume":"303","author":"EA Sadowski","year":"2022","unstructured":"Sadowski EA, Thomassin-Naggara I, Rockall A, Maturen KE, Forstner R, Jha P, Nougaret S, Siegelman ES, Reinhold C. O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee. Radiology 2022;303(1):35-47. https:\/\/doi.org\/10.1148\/radiol.204371","journal-title":"Radiology"},{"issue":"1","key":"3957_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12149-017-1216-x","volume":"32","author":"SP Campbell","year":"2018","unstructured":"Campbell SP, Baras AS, Ball MW, Kates M, Hahn NM, Bivalacqua TJ, Johnson MH, Pomper MG, Allaf ME, Rowe SP, Gorin MA. Low levels of PSMA expression limit the utility of (18)F-DCFPyL PET\/CT for imaging urothelial carcinoma. Annals of nuclear medicine 2018;32(1):69-74. https:\/\/doi.org\/10.1007\/s12149-017-1216-x","journal-title":"Annals of nuclear medicine"},{"issue":"1","key":"3957_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13550-016-0231-6","volume":"6","author":"H Rhee","year":"2016","unstructured":"Rhee H, Blazak J, Tham CM, Ng KL, Shepherd B, Lawson M, Preston J, Vela I, Thomas P, Wood S. Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour. EJNMMI research 2016;6(1):76. https:\/\/doi.org\/10.1186\/s13550-016-0231-6","journal-title":"EJNMMI research"},{"issue":"8","key":"3957_CR38","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12149-019-01371-8","volume":"33","author":"AR Meyer","year":"2019","unstructured":"Meyer AR, Carducci MA, Denmeade SR, Markowski MC, Pomper MG, Pierorazio PM, Allaf ME, Rowe SP, Gorin MA. Improved identification of patients with oligometastatic clear\u00a0cell renal cell carcinoma with PSMA-targeted (18)F-DCFPyL PET\/CT. Annals of nuclear medicine 2019;33(8):617-623. https:\/\/doi.org\/10.1007\/s12149-019-01371-8","journal-title":"Annals of nuclear medicine"},{"issue":"5","key":"3957_CR39","doi-asserted-by":"publisher","first-page":"e318","DOI":"10.1097\/rlu.0000000000002520","volume":"44","author":"P Verma","year":"2019","unstructured":"Verma P, Malhotra G, Goel A, Rakshit S, Chandak A, Chedda R, Banerjee S, Asopa RV. Differential Uptake of 68Ga-PSMA-HBED-CC (PSMA-11) in Low-Grade Versus High-Grade Gliomas in Treatment-Naive Patients. Clinical nuclear medicine 2019;44(5):e318-e322. https:\/\/doi.org\/10.1097\/rlu.0000000000002520","journal-title":"Clinical nuclear medicine"},{"issue":"4","key":"3957_CR40","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00259-016-3563-6","volume":"44","author":"M Sathekge","year":"2017","unstructured":"Sathekge M, Lengana T, Modiselle M, Vorster M, Zeevaart J, Maes A, Ebenhan T, Van de Wiele C. (68)Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients. European journal of nuclear medicine and molecular imaging 2017;44(4):689-694. https:\/\/doi.org\/10.1007\/s00259-016-3563-6","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"7","key":"3957_CR41","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1097\/rlu.0000000000001672","volume":"42","author":"J Kirchner","year":"2017","unstructured":"Kirchner J, Schaarschmidt BM, Sawicki LM, Heusch P, Hautzel H, Ermert J, Rabenalt R, Antoch G, Buchbender C. Evaluation of Practical Interpretation Hurdles in 68Ga-PSMA PET\/CT in 55 Patients: Physiological Tracer Distribution and Incidental Tracer Uptake. Clinical nuclear medicine 2017;42(7):e322-e327. https:\/\/doi.org\/10.1097\/rlu.0000000000001672","journal-title":"Clinical nuclear medicine"},{"issue":"6","key":"3957_CR42","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.eururo.2018.11.016","volume":"75","author":"MM Heck","year":"2019","unstructured":"Heck MM, Tauber R, Schwaiger S, Retz M, D'Alessandria C, Maurer T, Gafita A, Wester HJ, Gschwend JE, Weber WA, Schwaiger M, Knorr K, Eiber M. Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with (177)Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer. European urology 2019;75(6):920-926. https:\/\/doi.org\/10.1016\/j.eururo.2018.11.016","journal-title":"European urology"},{"key":"3957_CR43","doi-asserted-by":"publisher","unstructured":"Van de Wiele C, Sathekge M, de Spiegeleer B, De Jonghe PJ, Debruyne PR, Borms M, Beels L, Maes A. PSMA expression on neovasculature of solid tumors. Histology and histopathology 2020;35(9):919-927. https:\/\/doi.org\/10.14670\/hh-18-215","DOI":"10.14670\/hh-18-215"},{"key":"3957_CR44","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.2147\/ott.s172042","volume":"11","author":"JB Wu","year":"2018","unstructured":"Wu JB, Tang YL, Liang XH. Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy. OncoTargets and therapy 2018;11:6901-6909. https:\/\/doi.org\/10.2147\/ott.s172042","journal-title":"OncoTargets and therapy"},{"key":"3957_CR45","doi-asserted-by":"publisher","unstructured":"Grant CL, Caromile LA, Ho V, Durrani K, Rahman MM, Claffey KP, Fong GH, Shapiro LH. Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization. PloS one 2012;7(7):e41285. https:\/\/doi.org\/10.1371\/journal.pone.0041285","DOI":"10.1371\/journal.pone.0041285"},{"issue":"11","key":"3957_CR46","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2967\/jnumed.111.092650","volume":"52","author":"C Vangestel","year":"2011","unstructured":"Vangestel C, Van de Wiele C, Van Damme N, Staelens S, Pauwels P, Reutelingsperger CP, Peeters M. (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(11):1786-1794. https:\/\/doi.org\/10.2967\/jnumed.111.092650","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-03957-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-023-03957-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-03957-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T15:04:42Z","timestamp":1701183882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-023-03957-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3957"],"URL":"https:\/\/doi.org\/10.1007\/s00261-023-03957-3","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}